FDA clears myotrophin early-access program for patients with ALS

被引：0
|
作者：
不详
机构：
来源：
DRUG NEWS & PERSPECTIVES | 1996年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [31] An integrated early-access psoriasis clinic improves psoriasis severity, patient understanding and sense of disease control
    Cockroft, A.
    Welsh, C.
    Dharmaprasad, S.
    Martin-Smith, H.
    Warren, R. B.
    Griffiths, C. E. M.
    Cordingley, L.
    Reid, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 196 - 196
  • [32] Access to innovation through the national early access program and clinical trials for patients with malignant melanoma
    Christen, Claire
    Belgodere, Laetitia
    Guillot, Bernard
    Jumeau, Celine
    Lorence, Annie
    Kerouani-Lafaye, Ghania
    Brunel, Liora
    Turcry, Florence
    Monard, Adrien
    Grude, Francoise
    Guyader, Gaelle
    Boudali, Lotfi
    Albin, Nicolas
    CANCER, 2021, 127 (13) : 2262 - 2270
  • [33] Early experience with the FDA’s Breakthrough Devices program
    James L. Johnston
    Sanket S. Dhruva
    Joseph S. Ross
    Vinay K. Rathi
    Nature Biotechnology, 2020, 38 : 933 - 938
  • [34] Early experience with the FDA's Breakthrough Devices program
    Johnston, James L.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Rathi, Vinay K.
    NATURE BIOTECHNOLOGY, 2020, 38 (08) : 933 - 938
  • [35] Interim safety analysis of a compassionate-use program (CUP) and early-access program (EAP) providing cabazitaxel (Cbz) plus prednisone (P) to patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel
    Malik, Zafar I.
    Di Lorenzo, Giuseppe
    Basaran, Mert
    Ardavanis, Alexandros
    Parente, Phillip
    de Schultz, Wito
    Saad, Fred
    van Oort, Inge
    Gerritsen, Winald R.
    Aparicio, Luis M. Anton
    Matus, Geoffrey
    Hitier, Simon
    Heidenreich, Axel
    Bahl, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Living well: exploring experiences of carers of people with motor neurone disease attending an early-access support group
    Derbyshire, Julie
    Atkinson, Joanne
    Dunn, Yvonne
    Lowe, Julie-Anne
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2023, 30 (07):
  • [37] Evaluation of a pharmacist-led workflow for the FDA Expanded Access Program
    Barta, Blake T.
    Mcgee, Ann
    Arvik, Beth McLendon
    Vest, Tyler A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (17) : e520 - e527
  • [38] The international open-label early-access study of trifluridine/tipiracil (TAS-102) in patients with pretreated metastatic colorectal cancer (phase IIIb)
    Alfredo, Falcone
    Jean-Francois, Seitz
    Timothy, Price
    Lucjan, Wyrwicz
    Alice, Dorbon
    Natividad, Lopez Busto
    Nadjat, Mounedji
    Eric, Van Cutsem
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS)
    Yerton, Megan
    Winter, Allison
    Gelevski, Dario
    Addy, Grace
    Kostov, Anthony
    Lieberman, Cassandra
    Weber, Harli
    Doyle, Michael
    Kane, Geli
    Cohen, Caroline
    Parikh, Neil
    Burke, Katherine M.
    Rohrer, Margot
    Stirrat, Taylor
    Bruno, Margaret
    Hochman, Alison
    Luppino, Sarah
    Scalia, Jennifer
    D'Agostino, Derek
    Sinani, Ervin
    Yu, Hong
    Drake, Kristin
    Hagar, Jennifer
    Sherman, Alexander V.
    Babu, Suma
    Berry, James D.
    Cudkowicz, Merit E.
    Paganoni, Sabrina
    MUSCLE & NERVE, 2023, 67 (06) : 456 - 463
  • [40] May an early integrated care program with NIV adaptation delay NIV failure in patients with ALS?
    Vitacca, Michele
    Montini, Alessandra
    Bertella, Enrica
    Morini, Roberta
    Paneroni, Mara
    Lunetta, Christan
    Demattia, Elisa
    Lizio, Andrea
    Banfi, Paolo
    Volpato, Eleonora
    Lax, Agata
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345